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ABSTRACT: Pentacyclic triterpene-3-heptadecanoate (12,13-dihydro-α-amyrin-20,30-en-3-heptadeca -
no ate) ester  refers to the compound as a result  of  reaction between pentacyclic triterpene-3-ol 
(12,13-dihydro-α-amyrin-20,30-en-3-ol) and heptadecanoic acid. This research was aimed to conduct 
cytotoxicity test of pentacyclic triterpene-3-heptadecanoate; 12,13-dihydro-α-amyrin-20,30-en-3-ol 
and 12,13-dihydro-α-amyrin-20,30-en-3-acetate  esters against Hela cell line. The activity assay was 
carried out using MTT method. The results indicated that IC50 value of 12,13-dihydro-α-amyrin-3-
heptadecanoate; 12,13-dihydro-α-amyrin-20,30-en-3-acetate and 12,13-dihydro-α-amyrin-20,30-en-3-
ol were 111.0, 151.1 and 944.4 μg/ml, respectively. The compound of 12,13-dihydro-α-amyrin-20,30-
en-3-heptadecanoate had the lowest IC50 value, suggesting it has a potency to be synthesized as an 
anticancer drug.
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1. Introduction
Cancer is a disease that cause the loss of cell 
control towards both the regulation of cell cycle 
and homeostatic function leading to fast and 
uncontrolled proliferation [1].  A number of re­
searchs have been conducted to create new anti­
cancer compound. Isolation of natural substances 
known to have  anticancer activity have also been 
conducted.  By finding the lead compound hav­
ing some activities as anticancer, therefore, the 
chemi cal groups playing a role of having corres­
ponding activities can be determined. This, as 
a result, offers an opportunity to modify a lead 
compound in order to find a new more potential 
compound.  The natural compounds useful as the 
anticancer are 12,13-dihydro-α-amyrin-20,30-
en-3-ol and 12,13-dihydro-α-amyrin-20,30-en-
3­acetate that are categorized as the pentacyclic 
triterpenes. 
Pentacyclic triterpene­3­heptadecanoate ester 
(Figure 1) is the compound as the result of the 
synthesis of pentacyclic triterpene­3­ol and hep­
tadecanoic acid [2]. 12,13-dihydro-α-amyrin-
20,30-en-3-ol (pentacyclic triterpene) is also 
present in the Eupatorium inulifolium H.B.K 
leaves. Compound that can be isolated  from Eu-
patorium inulifolium is  12,13-dihydro-α-amyrin-
20,30-en-3-acetate [3]. Mulyadi [4],  reported 
that 12,13-dihydro-α-amyrin-20,30-en-3-ol and 
12,13-dihydro-α-amyrin-20,30-en-3-acetate 
are useful as  inhibitors of  protein kinase en­
zyme target in Hela cells (cervix cancer cell) 
in vitro, meaning to have the cytotoxic activity. 
12,13-dihydro-α-amyrin-20,30-en-3-acetate (es­
ter with C1) has IC50 value of 268.8 μg/ml while 
12,13-dihydro-α-amyrin-20,30-en-3-ol has IC50 
value of 628.9 μg/ml. [Figure 1]
Based on the calculation of the molecular dock­
ing score with the PLANTS program [5] towards 
the protein kinase enzyme target (code 3HMP), 
the result of the docking of pentacyclic triterpene 
ester with C9 was as much as (-80, 7), C14 (-84, 
3), C16 (-88, 5) and C15 (-87, 9). From those re­
sults, the pentacyclic triterpene ester with C16 
was chosen to be tested  its cytotoxic activity in 
which the pentacyclic triterpene ester with C16 
was as the pentacyclic triterpene­3­heptade ca­
noate ester that was possible to be more active 
than the pentacyclic triterpene­3­acetate ester. 
The selection of Hela cell line for the research was 
because it was in line with the purpose to be ap­
plied to human.  
Some problems emerging from this research 
included how the cytotoxic activity of the triter­
pene pentacyclic­3­heptadecanoate ester (C16) 
and whether it is more effective compared to the 
pentacyclic triterpene­3­acetate ester (C1).  Thus, 
the objective of this research is to find out the cy­
totoxic activity of triterpene pentacyclic­3­hep­
tadecanoate ester as the anticancer towards Hela 
cell line.  Hela cell line is cervix cancer cell that 
can be used for cancer research [6].
2. Methods 
2.1. Instrument and materials 
Laminar air flow cabinet (Labcono), 96-well 
microplate (Nucleon), eppendorf, Elisa reader 
(BioRad mode 680), incubator CO2 (Labcono), 
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centrifuge (PLC 01), pipette, tissue culture flask, 
vortex (Thermolyne Maximi), micropipette 
(Finnipipet Campus), refrigerator, Nebauer hae­
mocytometer, analytical scale, camera and a set 
of computer for docking.
The materials used are pentacyclic triterpene­
3­acetate,  pentacyclic triterpene­3­ol,  pentacy­
clic triterpene­3­heptadecanoate ester (result 
of esterification), MTT, Phosphate Buffered Sa­
line (PBS), Natrium Dodecyl Sulphate (SDS) and 
Hydrochloride Acid (HCl). Hela cell line was ob­
tained from LPPT UGM (Laboratory of Integrat­
ed Research and Testing of Universitas Gadjah 
Mada).
2.2.  Cytotoxicity test
Stock solution of 12,13-dihydro-α-amyrin- 
20,30-en-3-heptadecanoate was prepared by dis­
solving in dimethyl sulfoxide (DMSO) and media 
culture of RPMI 1640 was initially done in order to 
obtain a series of concentration from 15.6 to 500 
μg/ml. The 12,13-dihydro-α-amyrin-20,30-en-3-
acetate and 12,13-dihydro-amyrin-20,30-en-3-ol 
was also prepared in the series of concentration 
from 15.6 to 500 μg/ml. The Hela cell line with 
concentration of 20,000 cells/well were placed 
into 96-well plates containing RPMI 1640 with 
the volume of 100 μl/well were incubated within 
1 day.  A series of concentrations of pentacyclic 
triterpene­3­heptadecanoate ester were placed 
into the 100 μl wells. Here, triterpene pentacyclic 
triterpene ­3­heptadecanoate ester had a series 
of concentrations of 15.6 , 31.3, 62.5, 250 and 500 
μg/ml. Then, it was incubated within 24 hours 
in an incubator with 5% CO2 at the temperature 
of 37oC.  MTT with the concentration of 5 mg/ml 
in PBS was added to this compound before the 
compound was placed into each of 10-μl well and 
incubated for 4 hours in an incubator with 5% 
CO2 at 37oC.  The stop solution of 10% SDS in hy­
drochloride acid 0.01 N at 100 μl, subsequently, 
was added and incubated at room temperature. 
In this case, the absorbance of it was read using 
Elisa reader with the wavelength of 550 nm. 
The IC50 value was obtained from the analysis 
of regression from the result of absorbance ob­
tained. Based on the equation of y = Bx + A with x 
= the level of pentacyclic triterpene-3-heptadeca-
noate ester, pentacyclic triterpene­3­acetate 
ester, pentacyclic triterpene-3-ol and y = mean 
of the cell viability (%). Thus, the IC50 could be 
found by correlating percentage of cell viability 
at 50% at the equation. In this case, the IC50 value 
can be calculated as μg/ml and then divided with 
the molecular weight. The calculation of cell via­
bility is as follows:
       
sample Ab−media control Ab
 
viability =           x 100%
      
cell control of Ab−media control Ab
 Remark:  Ab = absorbance 
3. Results and discussion
The results of cytotoxicity test of pentacyclic 
triterpene­3­heptadecanoate ester, pentacyclic 
triterpene­3­acetate ester and triterpene pen­
tacyclic triterpene­3­ol against the Hela cell line 
(Table 1, 2, and 3) show that all of the compounds 
could inhibit the growth of Hela cells line with the 
IC50 value in the level of μg/ml.
The results of the cytotoxicity test of three 
pentacyclic triterpene compounds showed effect 
on the inhibition of the Hela cells’ growth.  The 
IC50 value of pentacyclic triterpene­3­heptadeca­
noate ester, pentacyclic triterpene­3­acetate es­
ter and pentacyclic triterpene-3-ol were 110.0, 
151.1 and 944.40 μg/ml, respectively. This shows 
that pentacyclic triterpene­3­heptadecanoate es­
ter as the result of modification had the lowest 
IC50 value. In other words,  esterification of  pen­
tacyclic triterpene­3­ol with heptadecanoic acid 
increased the  activity.
The highest concentration of compound se­
lected was 500 μg/ml. The relationship between 
percentage of viability of Hela cell line and the 
concentration of each compound are shown in 
Figure 2.
It can be seen from Figure 2 that the higher 
the concentration of the compounds, the smaller 
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Table 1. The viability test of triterpene pentacyclic­3­heptadecanoate ester (ETPH) against Hela cell line
Table 2. The viability test of triterpene pentacyclic­3­acetate ester (ETPA) against Hela cell line
Table 3. The viability test of triterpene pentacyclic-3-ol (TPOL) against Hela cell line
Compounds Docking score 
Triterpene pentacyclic-3-heptadecanoate ester  -88.5 
Triterpene pentacyclic-3-acetate ester -64.2 
Triterpene pentacyclic-3-ol -61.2 
 
Table 4. The results of the docking score between the triterpene pentacyclic­3­heptadecanoate ester, 
triterpene pentacyclic­3­acetate ester and triterpene pentacyclic­3­ol ester with the target of 
protein kinase enzymes (code 3HMP)




ester (μg/ml)  
Absorbance Viability (%) 
IC50 (μg/ml) 
1 2 3 1 2 3 Average 







250 0.165 0.168 0.168 11.50 11.75 11.76 11.67 
125 0.519 0.655 0.549 41.89 53.56 44.46 46.64 
62.5 0.665 0.812 0.735 54.42 67.04 60.43 60.63 
31.25 0.663 0.874 0.865 54.43 72.36 71.59 66.06 




3-acetate ester (μg/ml)  
Absorbance Viability (%) 
IC50 (μg/ml) 
1 2 3 1 2 3 Average 







250 0.452 0.421 0.427 36.14 33.48 33.99 34.53 
125 0.748 0.661 0.730 61.54 54.08 60.00 58.54 
62.5 0.714 0.680 0.962 58.63 55.71 79.91 64.75 
31.25 0.738 0.768 0.000 60.69 63.26 0.00 61.97 




3-ol (μg/ml)  
Absorbance Viability (%) 
IC50 (μg/ml) 
1 2 3 1 2 3 Average 







250 0.864 0.760 0.810 71.50 62.57 66.87 66.98 
125 0.871 0.000 0.804 72.10 0.00 66.35 69.23 
62.5 0.873 0.882 0.848 72.27 73.05 70.13 71.82 
31.25 0.834 1.170 0.802 68.93 97.77 66.18 77.73 
15.625 0.886 0.815 0.828 73.39 67.30 68.41 69.70 
 























Figure 2. The relationship between percentage of viability (y) of Hela cell line and the concentration (x)
of three different compounds (μg/ml) 
I.   Triterpene pentacyclic­3­heptadecanoate ester
II.  Triterpene pentacyclic­3­acetate ester
III. Triterpene pentacyclic­3­ol
the percentage of the viability is.  It means that 
the pentacyclic triterpene­3­ol had small effect 
to the percentage of viability. Moreover, the ef­
fect of pentacyclic triterpene­3­heptadecanoate 
ester on the growth of the Hela cell line at the 
concentration of 500 μg/ml was 1.63%, whereas 
at the concentration of 15.6 μg/ml was 66.32%. 
It means that there was a significant effect of the 
compound on the viability of Hela cell line.
The results in the docking score (Table 4) 
bet ween the compounds from the result of 
modification include pentacyclic triterpene com­
pound of 12,13-dihydro-α-amyrin-20,30-en-3-
hepadecanoate (ETPH) and the target of protein 
kinase enzymes (code 3HMP) at -88.5 as a quite 
good result in comparison to the compound of 
pentacyclic triterpene 12,13-dihydro-α-amyrin-
20,30-en-3-acetate (ETPA) at -64.2 and the com­
pound of pentacyclic triterpene 12,13-dihydro-α-
amyrin-20,30-en-3-ol (TP-ol) at -61.2. The dock­
ing result was in line with the result of its cyto­
toxicity test showing that the IC50 value for the 
compound of 12,13-dihydro-α-amyrin-20,30-en-
heptadecanoate was the lowest one (111.0 μg/
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 Figure 3. The bond between triterpene pentacyclic-12,13-diydro-α-amyrin-20,30-en-3-heptadecanoate 
ester (ETPH) and the target of protein kinase enzyme (3HMP)
 
Figure 4. The bond between triterpene pentacyclic-12,13-dihydro-α-amyrin-20,30-en-3-heptadecanoate 
ester (ETPH) and amino acid from the target of protein kinase enzymes (code 3HMP)
ml) if it was compared to that of 12,13­dihydro­
α-amyrin-20,30-en-3-acetate (151.1 μg/ml) and 
12,13-dihydro-α-amyrin-20,30-en-3-ol (944.4 μg/ 
ml). The supports for the result of the docking 
between the compound of pentacyclic triterpene 
12,13-dihydro-α-amyrin-20,30-en-3-heptade-
canoate with the target of enzymes code of 3HMP 
can be seen in Figure 3 and 4. 
The results showed a binding between 
the12,13-dihydro-α-amyrin-20,30-en-3-
heptadecanoate ester  and the target of protein 
kinase enzyme (code 3HMP) through its binding 
to Alanin 551 (Ala 551), Glycin 605 (Gly 605) and 
Aspartate 608 (Asp 608).
  
4. Conclusion
It can be concluded that pentacyclic triter­
pene-3-heptadecanoate could influence the 
growth of Hela cell line or it was cytotoxic to 
the Hela cell line. The IC50 value of pentacyclic 
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triterpene-12,13-dihydro-α-amyrin-20,30-en-
3­heptadecanoate ester (ETPH), pentacyclic 
triterpene-12,13-dihydro-α-amirin-20,30-en-3-
acetate ester and  pentacyclic triterpene­12,13­
dihydro-α-amyrin-20,30-en-3-ol were 111.0, 
151.1 and 944.4 μg/ml, respectively. Those com­
pounds were bound to the target of protein ki­
nase enzymes (code 3HMP) with the docking 
score -88.5, -64.2 and -61.2, respectively. It was 
also found that pentacyclic triterpene­12,13­
dihydro-α-amyrin-20,30-en-3-heptadecanoate 
(ester with C16) was more active than   pentacy­
clic  triterpene-12,13-dihydro-α-amyrin-20,30- 
en­3­acetate (ester with C1) towards Hela cell 
line.  It also had the most stable binding on tar­
get of protein kinase enzyme. Thus, the com­
pound of 12,13-dihydro-α-amyrin-20,30-en-3-
heptadecanoate can be suggested as the antican­
cer drug to the cervical cancer.  
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